The University of Chicago Header Logo

Connection

John Cursio to Paclitaxel

Back to Details
This is a "connection" page, showing publications John Cursio has written about Paclitaxel.
John Cursio
Connection Strength
0.047
Paclitaxel
  1. Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma. Br J Cancer. 2022 11; 127(8):1497-1506.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.